Am Board of Surgery (Sub: General Vascular Surg)
MD, University of Athens
St. Elizabeth's Hospital of Boston
Mount Sinai Hospital
St. Mary's Hospital
Fellowship, Vascular Surgery
University of Missouri Hospital
English, Greek, Italian
Randomized Multicenter Controlled Trial to Compare Best Endovascular versus Best Surgical Therapy in Patients with Critical Limb Ischemia
The purpose of this study is to evaluate the safety and efficacy of open vascular surgery compared to endovascular therapy as treatment options for critical limb ischemia (CLI), a medical problem diagnosed by a doctor. Both treatment options are considered accepted standard of ca...
A 24- Week Study of the Efficacy and Safety of Teduglutide in Subjects with Parental Nutrition-Dependent Short Bowel Syndrome CL0600-020
The purpose of this study is to see if an investigational drug called teduglutide is effective and safe. Teduglutide is similar to a protein the body makes. When people have SBS, their bodies do not make enough of the protein, and they have trouble getting nutrients and fluids fr...
Marrow StimTM PAD Kit for the Treatment of Critical Limb Ischemia (CLI) in Subjects with Severe Peripheral Arterial Disease (PAD)
This study aims to give an option for limb salvage to patients experiencing critical ischemia (loss of sufficient blood flow) in their lower limbs due to advanced peripheral arterial disease (PAD), and who have no other surgical treatment options. The body tries to compensate for...
The LUCY Study: TriVascular Evaluation of FemaLes who are Underrepresented Candidates for Abdonimal Aortic AneurYsm Repair
The purpose of this study is to evaluate whether the Ovation Abdominal Stent Graft Platform, which is a device used in the treatment of patients with abdominal aortic aneurysms (AAA), can improve clinical outcomes. An abdominal aortic aneurysm is a bulge in the aorta (the main ar...
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Vouyouka did not report having any of the following types of financial relationships with industry during 2015 and/or 2016: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.